Neon Therapeutics unveils new data in clinical trial of cancer vaccine
The study will evaluate the combination of NEO-PV-01 with nivolumab (anti-PD-1 therapy) in metastatic or…
German medical devices group Avatera considers stock market flotation
Avatera Medical has been developing robots to help surgeons in carrying out minimally invasive operations.…
Apple introduces heart monitoring feature in U.K. for its Watch users
The heart monitoring and ECG functions of the device have been CE marked, making them…
AstraZeneca confirms approval of Forxiga in Japan for type-1 diabetes
The approval resulted from reviewing the data from the phase 3 ‘DEPICT’ clinical programme and…
Theravance’s Ampreloxetine clinical data to be presented at 32nd ENC
The clinical data would be coming from the company’s phase-2 ampreloxetine clinical trials. The 20-week-long…
AstraZeneca’s Forxiga receives approval from European Commission
Forxiga is the first oral supplement approved in Europe as an adjunct for Type-1 diabetes…
Dermira to launch new campaign called ‘Life Unfolds’ featuring QBREXZA
The latest multi-channel consumer campaign is likely to feature several QBREXZA patients Dermira Inc., a…
Roche sues Utah-based Alliance in diabetes test strips reselling fraud
Roche has alleged that medical supply companies caused it to pay $87 million and that…
Zulresso wins FDA approval as the first post-partum depression drug
Zulresso will be provided through a restricted program in which a healthcare expert administers the…